- Home
- GRABW vs CRNX Comparison
GRABW vs CRNX Comparison
Compare GRABW & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRABW
- CRNX
- Stock Information
- Founded
- GRABW 2012
- CRNX 2008
- Country
- GRABW Singapore
- CRNX United States
- Employees
- GRABW 11267
- CRNX N/A
- Industry
- GRABW Business Services
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- GRABW Consumer Discretionary
- CRNX Health Care
- Exchange
- GRABW Nasdaq
- CRNX Nasdaq
- Market Cap
- GRABW N/A
- CRNX 2.8B
- IPO Year
- GRABW N/A
- CRNX 2018
- Fundamental
- Price
- GRABW $0.38
- CRNX $31.75
- Analyst Decision
- GRABW
- CRNX Strong Buy
- Analyst Count
- GRABW 0
- CRNX 8
- Target Price
- GRABW N/A
- CRNX $74.86
- AVG Volume (30 Days)
- GRABW 54.7K
- CRNX 725.8K
- Earning Date
- GRABW 02-21-2025
- CRNX 08-07-2025
- Dividend Yield
- GRABW N/A
- CRNX N/A
- EPS Growth
- GRABW N/A
- CRNX N/A
- EPS
- GRABW N/A
- CRNX N/A
- Revenue
- GRABW $2,686,000,000.00
- CRNX $760,000.00
- Revenue This Year
- GRABW N/A
- CRNX $402.02
- Revenue Next Year
- GRABW N/A
- CRNX $771.03
- P/E Ratio
- GRABW N/A
- CRNX N/A
- Revenue Growth
- GRABW 21.65
- CRNX N/A
- 52 Week Low
- GRABW $0.15
- CRNX $24.10
- 52 Week High
- GRABW $0.59
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- GRABW 48.92
- CRNX 57.94
- Support Level
- GRABW $0.38
- CRNX $28.98
- Resistance Level
- GRABW $0.40
- CRNX $32.49
- Average True Range (ATR)
- GRABW 0.03
- CRNX 1.24
- MACD
- GRABW 0.00
- CRNX 0.30
- Stochastic Oscillator
- GRABW 66.67
- CRNX 90.54
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.